Read more
List of contents
SECTION I: General Considerations
Chapter 1: Basic Science of Spinal Receptors
Chapter 2: Pharmacologic Agents and Compounding of Intrathecal Drugs
Chapter 3: Polyanalgesia for Implantable Drug Delivery Systems
Chapter 4: Principles of Patient Management for Intrathecal Analgesia
Chapter 5: Patient Selection for Intrathecal Infusion to Treat Chronic Pain
Chapter 6: Patient Preparation
Chapter 7: Psychological Considerations in IDD
Chapter 8: Intrathecal Drug Delivery: Medical Necessity, Documentation, Coding and Billing
SECTION II: Implant Devices
Chapter 9: Methods of Trials for Consideration of ITDDS
Chapter 10: Techniques of Implant Placement for Intrathecal Pumps
Chapter 11: Programmable versus Fixed-Rate Pumps for Intrathecal Drug Delivery
Chapter 12: SynchroMed EL vs SynchroMed II
Chapter 13: Minimizing the Risks of Intrathecal Therapy
Chapter 14: Complications Associated with Intrathecal Drug Delivery Systems
SECTION III: Evidence-based practice
Chapter 15: Management of ITDDS in Patients with Co-Morbidities
Chapter 16: Cost-Effectiveness of Implanted Drug Delivery Systems
Chapter 17: Neuroaugmentation by Stimulation vs. Intrathecal Drug Delivery Systems
Chapter 18: Anticoagulation guidelines and Intrathecal Drug Delivery Systems
Chapter 19: Intrathecal Therapy for Malignant Pain
SECTION IV: ITDDs for spasticity
Chapter 20: Intrathecal Baclofen Trialing
Chapter 21: Baclofen Pump Management
SECTION V: Future of ITDDs
Chapter 22: Future of Intrathecal Drug Delivery Systems (including new devices)
Chapter 23: Trialing for Ziconotide Intrathecal Analgesic Therapy
Chapter 24: Perioperative Management of Patients with ITDDS
About the author
Dr. Timothy Deer is the President and CEO, The Spine and Nerve Center of The Virginias, Clinical Professor of Anesthesiology and Pain Medicine of the WVU School of Medicine, Chairman, American Society of Pain and Neuroscience, Past President, INS and past president WVSIPP.
